Premier Alternatives

DMC Biotechnologies

Boulder, CO · Founded 2014 · Privately Held (backing)

Developer of bio-based chemicals designed for low-cost, sustainable transformation of multiple product markets. DMC Biotechnologies is based in Boulder, CO and was founded in 2014. Its last reported valuation was $104 million in Dec 2021. It has raised $55 million across 6 recorded rounds; the latest was a $1.4 million seed round in Dec 2025.

Last reported valuation
$104.0M
Oct 2026
Priced at
—
Total raised
$55.0M
Last round
Seed Round
Dec 2025

DMC Biotechnologies key facts

as of Oct 2026
  • Developer of bio-based chemicals designed for low-cost, sustainable transformation of multiple product markets.
  • DMC Biotechnologies is valued at approximately $104.0M as of Oct 2026 (last reported valuation).
  • It has raised $55.0M across 6 recorded rounds; the latest was Seed Round ($1.4M) in Dec 2025.
  • Notable investors include US National Science Foundation, U.S. Department of Energy, Breakthrough Energy, United States Department of Agriculture, Sofinnova Partners — 22 tracked in total.
  • DMC Biotechnologies has filed 7 Form Ds with the SEC since 2018, most recently Apr 2025 ($4.8M sold to 9 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$104.0M

DMC Biotechnologies's last reported valuation, Dec 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of DMC Biotechnologies with a free account
  • ·The complete investor list: 22 names
  • ·Watch DMC Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

DMC Biotechnologies funding rounds

6 rounds
Dec 2025Seed Round$1.4MSEC filing▮
Oct 2025Seed Round$905KSEC filing▮
Apr 2025Seed Round$4.8MSEC filing▮
Nov 2021Early Stage VC$33.8MSEC filing▮
Jun 2019Seed Round$4.6MSEC filing▮
Full funding history →

DMC Biotechnologies valuation

DMC Biotechnologies's last reported valuation was $104 million in Dec 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has DMC Biotechnologies raised?

DMC Biotechnologies has raised $55 million across 6 recorded rounds since 2018. The largest was a $904,500 seed round in Oct 2025; the most recent was a $1.4 million seed round in Dec 2025.

DMC Biotechnologies has filed 7 Form Ds with the SEC since 2018, most recently in Apr 2025 ($4.8 million sold to 9 investors).

DMC Biotechnologies investors

22 investors are on record for DMC Biotechnologies, including US National Science Foundation, U.S. Department of Energy, Breakthrough Energy and United States Department of Agriculture. The seed round in Dec 2025 drew 7 investors.

About DMC Biotechnologies

Developer of bio-based chemicals designed for low-cost, sustainable transformation of multiple product markets. The company's chemicals use engineered microbes for enhanced fermentation instead of extracting ingredients from finite agricultural resources that are subject to extreme weather and climate change, enabling clients to reduce biological complexity enhance the speed of development, and grow sustainably.

Sector
Healthcare
HQ
Boulder, CO, United States
Founded
2014
Employees
51
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.